Your session is about to expire
← Back to Search
Group-Based Prenatal Care for Preventing Premature Birth
N/A
Recruiting
Led By Britni L Ayers, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up all maternal and infant health records will be collected at six weeks postpartum
Awards & highlights
No Placebo-Only Group
Summary
This trial will measure if group-based prenatal care with care navigation can improve health outcomes for US Pacific Islanders, reducing infant & maternal mortality & morbidity.
Who is the study for?
This trial is for pregnant Marshallese women, aged 18 or older, who are in their first trimester (12-14 weeks gestation). It's not open to those who used fertility treatments, have a high-risk pregnancy requiring special care, are expecting multiple babies, or take medications that affect fetal growth.
What is being tested?
The study tests 'Centering Pregnancy with Care Navigation' against standard prenatal care. It aims to see if this group-based program can improve attendance at care appointments and outcomes like preterm birth rates and infant weight.
What are the potential side effects?
Since the intervention involves supportive group prenatal programs rather than medication, there aren't typical side effects. However, participants may experience varying levels of emotional comfort or stress due to the social nature of the program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ all maternal and infant health records will be collected at six weeks postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~all maternal and infant health records will be collected at six weeks postpartum
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of participants with a caesarean delivery.
Number of participants with infants that are preterm.
Number of participants with infants with low birthweight
Secondary study objectives
The number of social services participants are enrolled in at the end of the intervention.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Centering Pregnancy with Care Navigation for pregnant Marshallese womenExperimental Treatment1 Intervention
Forty pregnant Marshallese women will be enrolled in the group prenatal intervention, Centering Pregnancy, with care navigation to determine the feasibility of the intervention and the preliminary effectiveness to improve maternal and infant health care outcomes.
Group II: Pregnant Marshallese women enrolled in standard prenatal careActive Control1 Intervention
We will use a 1:1 propensity score matching with pregnant Marshallese women who completed standard prenatal care to compare their maternal and infant health care outcomes with those participants enrolled in the intervention.
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
495 Previous Clinical Trials
150,330 Total Patients Enrolled
1 Trials studying Premature Birth
30 Patients Enrolled for Premature Birth
Britni L Ayers, PhDPrincipal InvestigatorUniversity of Arkansas for Medical Sciences Northwest
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently 12-14 weeks pregnant.I am not taking medications that can affect fetal growth.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Centering Pregnancy with Care Navigation for pregnant Marshallese women
- Group 2: Pregnant Marshallese women enrolled in standard prenatal care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger